Recent trends in mesoporous carbon-based nanoplatforms for biomedical application

Wei Yang1, Jinnian Ge2, Mohan Jiang3

  • 1Department of Infectious Disease, Shengjing Hospital of China Medical University, Shenyang, 110004, China.

PubMed
Summary

Mesoporous carbon nanoparticles (MCNs) offer advanced drug delivery and therapy solutions. Their unique properties enhance drug loading, release, and biocompatibility for improved biomedical applications.